Lifecore Biomedical Inc
NASDAQ:LFCR
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3.815
8.55
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lifecore Biomedical Inc
Lifecore Biomedical Inc
Cost of Revenue
Lifecore Biomedical Inc
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecore Biomedical Inc
NASDAQ:LFCR
|
Cost of Revenue
-$83.9m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
30%
|
CAGR 10-Years
15%
|
|
|
Hershey Co
NYSE:HSY
|
Cost of Revenue
-$6.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
|
General Mills Inc
NYSE:GIS
|
Cost of Revenue
-$12.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Kellogg Co
NYSE:K
|
Cost of Revenue
-$6.8B
|
CAGR 3-Years
11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
2%
|
|
|
Kraft Heinz Co
NASDAQ:KHC
|
Cost of Revenue
-$17.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Mondelez International Inc
NASDAQ:MDLZ
|
Cost of Revenue
-$22.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
0%
|
|
Lifecore Biomedical Inc
Glance View
Lifecore Biomedical, Inc. engages in the design, development, manufacture, and sale of health and wellness products for food and biomaterials markets. The company is headquartered in Chaska, Minnesota and currently employs 689 full-time employees. The firm offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials, as well as the manufacture of pharmaceutical-grade Hyaluronic Acid. The company provides complete CDMO services for injectable pharmaceuticals and medical devices. The Company’s services include sodium hyaluronate, development, manufacturing, and analytical services. The company offers a range of average molecular weights and custom modifications for research and development (R&D), clinical, and commercial applications. The Company’s therapeutic applications include drug delivery, biomaterials, ophthalmology, orthopedics, aesthetics, oncology, and pain management. Its development capabilities include formulation, sterile filtration, filling, packaging, testing, and secondary sterilization.
See Also
What is Lifecore Biomedical Inc's Cost of Revenue?
Cost of Revenue
-83.9m
USD
Based on the financial report for Aug 25, 2024, Lifecore Biomedical Inc's Cost of Revenue amounts to -83.9m USD.
What is Lifecore Biomedical Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
15%
Over the last year, the Cost of Revenue growth was -40%. The average annual Cost of Revenue growth rates for Lifecore Biomedical Inc have been -37% over the past three years , 30% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
